latest news in companies

NextNRG Unveils Digital Fuel Tokens to Reward Shareholders and Boost Platform Engagement

NextNRG Unveils Digital Fuel Tokens to Reward Shareholders and Boost Platform Engagement

Miami, Wednesday, 31 December 2025.
NextNRG is linking equity to utility by issuing transferable digital fuel tokens to shareholders today, a strategic move following a massive 227% revenue spike in the third quarter.

FLUENT Corp. Sells Pennsylvania Operations for $12.5 Million to Streamline Strategy

FLUENT Corp. Sells Pennsylvania Operations for $12.5 Million to Streamline Strategy

Tampa, Wednesday, 31 December 2025.
FLUENT Corp. closed 2025 by selling its Pennsylvania operations for $12.5 million in cash, a strategic pivot designed to slash debt and sharpen focus on core growth markets.

TSMC Investors Favor Bullish Options Strategies Ahead of January Earnings Report

TSMC Investors Favor Bullish Options Strategies Ahead of January Earnings Report

Hsinchu, Wednesday, 31 December 2025.
Investors are utilizing bullish option spreads ahead of the January 15 earnings, banking on TSMC’s dominant AI chip position to navigate potential volatility in the semiconductor sector.

NANO Nuclear Energy to Deploy First Microreactor on U.S. University Campus

NANO Nuclear Energy to Deploy First Microreactor on U.S. University Campus

Urbana, Wednesday, 31 December 2025.
On December 31, 2025, NANO Nuclear Energy (NASDAQ: NNE) signed a pivotal Memorandum of Understanding with the University of Illinois Urbana-Champaign to construct the KRONOS MMR™ energy system. This collaboration aims to establish the first operational microreactor on American university grounds, a significant milestone for decentralized power infrastructure and zero-carbon energy targets. Despite a slight market dip to $24.89 following the announcement, the company maintains a strong financial footing with $580 million in cash to support this regulatory-heavy endeavor. This project not only advances portable nuclear technology but also positions the university as a central hub for energy innovation.

Lassila & Tikanoja Finalizes Strategic Split into Two Distinct Listed Entities

Lassila & Tikanoja Finalizes Strategic Split into Two Distinct Listed Entities

Helsinki, Wednesday, 31 December 2025.
Effective December 31, 2025, Lassila & Tikanoja has officially separated its operations. This strategic demerger creates Luotea Plc and a new independent Lassila & Tikanoja, the latter positioned to capitalize on a global circular economy market projected to exceed $4.5 trillion by 2030.

Brown & Brown Schedules Release of Fourth-Quarter Financial Results for Late January

Brown & Brown Schedules Release of Fourth-Quarter Financial Results for Late January

Daytona Beach, Wednesday, 31 December 2025.
The insurance brokerage confirms it will report year-end financials on January 26, offering investors a critical look at performance following recent acquisition-led growth and ongoing talent retention challenges.

Alexandria Real Estate and DeFi Technologies Face Class Actions After Major Stock Declines

Alexandria Real Estate and DeFi Technologies Face Class Actions After Major Stock Declines

New York, Wednesday, 31 December 2025.
Investors reeling from a 27% drop in DeFi and 19% slide in Alexandria shares face January 2026 deadlines to join new securities fraud litigation.

Insilico Medicine Surges in Hong Kong Debut, Marking 2025’s Largest Biotech IPO

Insilico Medicine Surges in Hong Kong Debut, Marking 2025’s Largest Biotech IPO

Hong Kong, Wednesday, 31 December 2025.
On December 30, 2025, Insilico Medicine (3696.HK) successfully listed on the Hong Kong Stock Exchange, raising HKD 2.277 billion ($293 million) in the year’s largest biotech IPO. The debut underscores robust investor appetite for AI-driven healthcare, with shares jumping significantly from the issue price of HKD 24.05 following a staggering 1,427-times oversubscription of the public offering. As the first AI-biotech firm listed under the HKEX’s Chapter 8.05 rules, this event marks a pivotal validation of generative AI in drug discovery. Proceeds are earmarked to accelerate clinical pipelines and enhance proprietary AI models. The listing coincides with a broader recovery in the region’s capital markets, highlighted by a 67% surge in the Hang Seng Biotech Index throughout 2025.

Capital Bancorp Restructures Executive Leadership to Drive Long-Term Enterprise Expansion

Capital Bancorp Restructures Executive Leadership to Drive Long-Term Enterprise Expansion

Rockville, Wednesday, 31 December 2025.
Capital Bancorp (NASDAQ: CBNK) strategically bifurcates leadership, renewing Ed Barry as holding company CEO through 2027 while appointing Steve Poynot to lead the subsidiary bank. This move distinctively separates enterprise strategy from operational execution to optimize the $3.4 billion firm’s diversified growth.

Triller Group Appeals Nasdaq Delisting Determination After Filing Delay

Triller Group Appeals Nasdaq Delisting Determination After Filing Delay

Los Angeles, Tuesday, 30 December 2025.
Triller Group faces Nasdaq delisting due to a technical accounting error. The company has filed an emergency SEC stay to halt the suspension, insisting its core operations remain unaffected.